Delhi's eyes are under siege from pollution and relentless screen time, leading to a surge in dry eye disease. Smog irritates, while reduced blinking ...

Epioxa by Glaukos Corp received US Food and Drug Administration (FDA) approval on 20 October as the first and only ...

Q3 2025 Earnings Call Transcript October 30, 2025 Operator: Ladies and gentlemen, thank you for standing by. My name is Colby ...

CDC warns that a parasitic illness called Chagas disease is now endemic — or always present — in several states. Biting insects called kissing bugs have been identified in 32 states, predominantly in ...

The Eye Care Network sat down with Rajesh K. Rajpal, MD, ophthalmologist and founder of See Clearly Vision Group in McLean, ...

Many eye banks won't accept corneas from donors with diabetes, concerned they might be harder to prepare for transplant surgery or are more likely to fail.

Rubbing your eyes, though seemingly harmless, can lead to serious health issues. It increases infection risk, damages the ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare ...

Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

ORLANDO -- Receiving corneal tissue from donors with and without diabetes didn't negatively affect patients who underwent ...

Glaukos Corp. today announced it received FDA approval for Epioxa, an eye therapy made to stop the progression of keratoconus.

Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to corneal cross-linking procedures.